Dr. Strickler is an Associate Professor of Medicine in the Division of Medical Oncology at Duke University. His clinic focuses on the treatment of gastrointestinal malignancies, with a particular emphasis on gastroesophageal, pancreatic, and colorectal cancers. As leader of the Duke Cancer Institute Molecular Tumor Board, Dr. Strickler directs precision cancer medicine efforts. In addition, he is the Associate Director for Clinical Research — GI Oncology at Duke University. He has served as principal investigator for over 50 clinical trials and is a member of the American Society of Clinical Oncology Treatment Guidelines Committee for Advanced Colon Cancer.
His research focuses on the design and execution of first-in-human and investigator-initiated clinical trials. He has a particular interest in non-invasive testing to identify and treat genomic drivers of treatment resistance. Dr. Strickler has recently served as Co-Chair of the GI Steering Committee for the Academic and Community Cancer Research United (ACCRU) clinical trial consortium.
Dr. Strickler received his B.A. from the University of North Carolina at Chapel Hill where he was a Morehead Scholar, and his MD from the University of Chicago Pritzker School of Medicine. He completed his residency in Internal Medicine at the University of Washington and fellowship in Hematology and Medical Oncology at Duke University.
